Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 19 2024
0mins
Source: Benzinga
Mpox Outbreak and Global Response: Authorities in Europe and China are increasing screening for a new strain of mpox, known as clade I, which has been confirmed in Sweden and is spreading in Africa. The World Health Organization has declared it a global health emergency, with over 16,000 cases reported in Africa this year.
Vaccination Efforts and Treatment Challenges: Two vaccines have received emergency authorizations, with efforts to expand their use among at-risk populations. However, a study indicated that the antiviral drug tecovirimat did not reduce the duration of mpox lesions in affected individuals.
Analyst Views on SFLO
Wall Street analysts forecast SFLO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SFLO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 30.189
Low
Averages
High
Current: 30.189
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
